Incontinence News and Research

Latest Incontinence News and Research

Cymbalta, treatment for major depression hits the market

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company has announced.

26 Aug 2004

Cymbalta, a new treatment for major depression

Cymbalta, a new treatment for major depression, is now available by prescription in pharmacies across the United States, Eli Lilly and Company have announced.

25 Aug 2004

Pfizer drug effectively treats overactive bladder symptoms

Women with mixed incontinence, a combination of overactive bladder and stress incontinence, reported a greater treatment benefit for overactive bladder symptoms from DETROL® LA (tolterodine tartrate extended release capsules) than placebo, according to new study results published in the August issue of Urology.

21 Aug 2004

Evidence of pelvic floor nerve injury after routine vaginal birth

Women with pelvic floor disorders suffer from urinary and fecal incontinence as well as prolapse of the bowel, bladder and reproductive organs. (Bowel prolapse occurs when the bowel slips out of place, and pushes up against the walls of the vagina, which may cause a great deal of discomfort.)

20 Aug 2004

Study to compare prostate surgery and drugs

The Minimally Invasive Surgical Therapies (MIST) Consortium for Benign Prostatic Hyperplasia (BPH) has launched a new study to compare long-term benefits and risks of transurethral needle ablation (TUNA) and transurethral microwave thermotherapy (TUMT) to a regimen of the alpha-1 inhibitor alfuzosin and the 5-alpha reductase inhibitor finasteride.

20 Aug 2004

Researchers find way to detect dangerous brain swelling in diabetic children

A rare swelling of the brain that is nonetheless the most common diabetes-related cause of death for children with the disease could be caught earlier — potentially saving lives — if practitioners learn to recognize key signs, researchers at the University of Florida report.

18 Aug 2004

Approval of Cymbalta for treatment of major depressive disorder

The U.S. Food and Drug Administration has approved Cymbalta® (duloxetine HCl; pronounced SIM-BALL-TA), judging it a safe and effective treatment for major depressive disorder, Eli Lilly and Company have announced.

5 Aug 2004

State-of-the-art laparoscopic robotic technology sends most prostate patients home the day after surgery

As recently as three years ago, the gold standard to treat prostate cancer, the second most common form of cancer in men, was an invasive surgery that required up to a one-week hospital stay.

2 Aug 2004

New tool that measures and assesses first and second-degree perineal tears

A researcher from the University of Birmingham has co-developed a device to significantly improve the maternity aftercare of many new mothers - and the invention could also help lead the way in forensic investigations.

9 Jul 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

As many prostate-cancer survivors have discovered, the lifesaving benefits of surgery, radiation and hormone therapy can come with a cost.

29 Jun 2004

Duloxetine reduces stress urinary incontinence and improves quality of life for women

Data presented today at the 3rd International Consultation on Incontinence, provide evidence for the efficacy of duloxetine, an investigational agent for the treatment of women with stress urinary incontinence (SUI).

29 Jun 2004

Blood hormone may be key to appetite suppression and obesity control

How the body naturally regulates appetite through the presence of a blood hormone may offer the prospect of a safer and more effective method of weight control, according to Dr. Leonard Firestone of Manhattan Pharmaceuticals.

28 Jun 2004

New operating room with 3-dimensional technology that takes modern robotic surgery to new levels

Surgical teams are now performing robotic surgery for prostate cancer with enhanced efficiency, comfort and communication using this unique technology.

15 Jun 2004

Accurately estimating the life expectancy of persons with advanced dementia

A model has been created that can help determine the risk of death within six months for nursing home patients with advanced dementia, according to a study in the June 9 issue of The Journal of the American Medical Association (JAMA).

10 Jun 2004

Fibroid tumors lack crucial structural protein

Fibroid tumors-the sometimes painful uterine growths affecting many American women-lack a key protein that plays a role in holding tissues together, according to a study by researchers from the Uniformed Services University of the Health Sciences (USUHS) and the National Institute of Child Health and Human Development of the National Institutes of Health

3 Jun 2004

Fibroid tumors affecting many American women lack a key protein helps hold tissues together

Fibroid tumors — the sometimes painful uterine growths affecting many American women — lack a key protein that plays a role in holding tissues together, according to a study by researchers from the Uniformed Services University of the Health Sciences (USUHS) and the National Institute of Child Health and Human Development of the National Institutes of Health.

2 Jun 2004

Current test for prostate cancer is inadequate

Britain’s top cancer scientists claim that men’s health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.

27 May 2004

Men with low prostate specific antigen levels on screening tests can still have prostate cancer

Men with low PSA (prostate specific antigen) levels on screening tests can still have prostate cancer, according to a study* released today by scientists from the National Cancer Institute (NCI).

27 May 2004

New software that combines assessment and exercise prescription for people undergoing hydrotherapy

In 2001, CQU postgraduate student Sandy Dalton commenced research in Health and Human Performance (HHP) focussing on developing new computer software that combines assessment and exercise prescription for people undergoing hydrotherapy.

26 May 2004